Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PTTKT: TB Prophylaxis in Kidney Transplant
NCT05249699Unknown
- Sponsor
- West China Hospital of Sichuan University
- Start
- Apr 2022
- Primary completion
- Jul 2023
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of isoniazid in Tuberculosis (TB) (3 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Incidence of tuberculosis at 12 months. Status: unknown.
02
Drugs
isoniazid
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT05249699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05249699.